Company Number: 12635168

Analysis Date: 2025-07-20 16:09 UTC

1. Risk Rating: HIGH
   The company shows negative net assets as of the latest financial year (2024), indicating insolvency on a balance sheet basis. The erosion of shareholders’ funds from £118 in 2023 to a negative £458 in 2024, combined with current liabilities exceeding current assets, signals significant solvency and liquidity risk.

2. Key Concerns:

• Solvency deterioration: Shareholders’ funds have declined sharply into negative territory, implying that liabilities exceed assets. This raises concerns about the company’s ability to meet long-term obligations.
• Working capital deficit: Current liabilities (£567) now exceed current assets (£109), resulting in negative net current assets (-£458), which suggests liquidity challenges in covering short-term debts.
• Lack of operational scale and revenue data: Being a micro-entity with no employees and minimal capital (£100 share capital) limits the company’s operational capacity and resilience. The absence of a profit and loss account prevents assessment of profitability or cash flow generation.

3. Positive Indicators:

• Timely filings: The company is up to date with both accounts and confirmation statement filings, indicating compliance with statutory requirements and good governance in this respect.
• Single controlling director: Ms. Aisling O’Leary has full control and has maintained consistent directorship since incorporation, which may contribute to stable management oversight.
• Micro-entity status: Reduced reporting requirements lower administrative burden and costs, appropriate for very small companies.

4. Due Diligence Notes:

• Investigate the reason for the sharp decline in net assets and working capital between 2023 and 2024. Review detailed financials if available outside the micro-entity filing for cash flow insights.
• Clarify the company’s business model and revenue streams under SIC 66300 (fund management activities) given the absence of employees and minimal assets.
• Confirm whether there are any contingent liabilities or off-balance sheet obligations that may further affect financial health.
• Assess related party transactions or director loans that might impact solvency or liquidity.
• Review any external funding arrangements or planned capital injections to address net liability position.